Following non-submission
AWMSG advice |
||
Status: Not endorsed (Statement of Advice) | ||
In the absence of a submission from the holder of the marketing authorisation, mometasone furoate (Nasonex®) cannot be endorsed for use within NHS Wales for use in children aged 3 to 6 years to treat the symptoms of seasonal allergic or perennial rhinitis. |
||
|
||
Medicine details |
||
Medicine name | mometasone furoate (Nasonex®) | |
Formulation | 50 micrograms/actuation nasal spray | |
Reference number | 2894 | |
Indication | For use in children aged 3 to 6 years to treat the symptoms of seasonal allergic or perennial rhinitis. |
|
Company | Merck Sharp & Dohme Ltd | |
BNF chapter | Ear, nose & oropharynx | |
Assessment type | Non-submission | |
Status | Not endorsed (Statement of Advice) | |
Ratification by Welsh Government | 09/12/2015 | |
Date of issue | 10/12/2015 |